Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

In 2023, ACCC hosted a series of interactive sessions at the ACCC 49th Annual Meeting and Cancer Center Business Summit to collect insights and solutions into 8 key areas.
Dental Management of the Oncology Patient Jessica Pharar, DMD Pharar Foundation Financial Disclosures  No financial disclosures to report Pre-treatment How much dentistry do we do before the patient starts their care? Modulated by patient’s prognosis and health status Good quality, clear communication with oncology care team is essential …
Microsoft PowerPoint - Trends in HPV-Related Cancers in New Mexico 16Sep2023 Epidemiology and Prevention of Head & Neck Cancer Charles Wiggins, Ph.D. Director and Principal Investigator New Mexico Tumor Registry New Mexico Society of Clinical Oncology Saturday – September 15, 2023 Outline • Public Health Surveillance for Cancer • New Mexico Tumor Registry • …
Nutritional Interventions for Head and Neck Cancer patients Nutrition for Head & Neck Cancer Patients Teresa Miller, MS, RDN, LDN tmiller@agilixhealth.com Nutritional Challenges for HNC Patients Radiotherapy • Dysgeusia & ageusia • Xerostomia • Mucositis • Odynophagia • Dysphagia • Thrush • Increased or thick secretions • Anorexia Chemotherapy • Dysgeusia & ageusia …
PowerPoint Presentation Case 1: Surgeon’s Two Cents ANDREW COWAN, MD, PHD NMSCO ANNUAL CONFERENCE, 9/15/23 Tonsil?  2.8 x 2.6 cm mass in the left pharyngeal space [assume oropharynx]  The oropharynx is bounded anteriorly by the oral cavity, superiorly by the nasopharynx, and inferiorly by the larynx and the hypopharynx. Nasopharynx  Bounded anteriorly by …
Speech Language Pathologists Speech Language Pathologists Contribution for Head and Neck Cancer Patients What do Speech Language Pathologists specialize in?  Speech  Language  Swallowing  Cognitive communication  Social communication  Auditory processing  Fluency  Voice disorders  AAC (Alternative and augmentative communication)  Disorders we might see in our …
On September 11, 2023, ACCC submitted comment letters to the Centers for Medicare and Medicaid Services (CMS) on the proposed physician fee schedule (PFS) and hospital outpatient prospective payment system (OPPS) regulations. Among other topics, ACCC supported the proposal for Medicare reimbursement for principal illness navigation (PIN) services to assist those with serious illnesses such as …
SCOS ONCOLOGY DRUG NEWSLETTER S E P T E M B E R 2 0 2 3 This content is being shared with permission from MJH Life Sciences. All content of Targeted Oncology is independently created and owned by MJH Life Sciences. FDA APPROVALS Blinatumomab (Blincyto) The FDA awarded full approval to blinatumomab (Blincyto) for the treatment of adults and pediatric patients with CD19-positive B-cell …
TxSCO 9.23 Attendee Roster as of 9.14.xlsx TxSCO 2023 Annual Conference September 23, 2023 Hyatt Regency Frisco Dallas Frisco, TX Attendee Roster First Name Last Name Title Account Name Ashley Barlow PharmD AbbVie Inc. Jigar Trivedi Medical Science Liaison (Hematology) AbbVie Inc. Kristin Evans Account Executive AbbVie Inc. Mary Peterson Nurse Practitioner/Oncology Clinical …
NCOA ONCOLOGY DRUG NEWSLETTER S E P T E M B E R 2 0 2 3 This content is being shared with permission from MJH Life Sciences. All content of Targeted Oncology is independently created and owned by MJH Life Sciences. FDA APPROVALS Blinatumomab (Blincyto) The FDA awarded full approval to blinatumomab (Blincyto) for the treatment of adults and pediatric patients with CD19-positive B-cell …
TACOS ONCOLOGY DRUG NEWSLETTER S E P T E M B E R 2 0 2 3 This content is being shared with permission from MJH Life Sciences. All content of Targeted Oncology is independently created and owned by MJH Life Sciences. FDA APPROVALS Blinatumomab (Blincyto) The FDA awarded full approval to blinatumomab (Blincyto) for the treatment of adults and pediatric patients with CD19-positive B-cell …
TxSCO ONCOLOGY DRUG NEWSLETTER S E P T E M B E R 2 0 2 3 This content is being shared with permission from MJH Life Sciences. All content of Targeted Oncology is independently created and owned by MJH Life Sciences. FDA APPROVALS Blinatumomab (Blincyto) The FDA awarded full approval to blinatumomab (Blincyto) for the treatment of adults and pediatric patients with CD19-positive B-cell …
PowerPoint Presentation September 14, 2023 TxSCO Update Overview: Notable Updates 2 Federal • First 10 drugs selected for IRA negotiation • No Surprises Act • Medicaid unwinding • Comments on the PFS Proposed Rule State • AG Impeachment Trial Update • Upcoming Special Session • Legislative Retirements Federal Updates CMS …
September 13, 2023
Immerse yourself in exhilarating discussions and innovative ideas for overcoming the most relevant and daunting challenges in oncology to-date. Hear from local and national visionaries on effective practices for delivering optimal care, and make new connections—and strengthen existing ones—through unlimited networking opportunities.If you are employed by a pharmaceutical/device …
Developing a Health Literacy and Clear Communications e-Course FRIDAY, OCTOBER 6, 2023 8:00 am Registration/Breakfast 9:00 am Welcome & Introductions Rahul Seth, DO President, Empire State Hematology & Oncology Society 9:15 am Clinical Trial Health Disparities Jimmy Ruiz, MD Wake Forest University 10:00 am Value Based Care in Cancer – Where Will We Go from Here? CJ Stimson, MD, JD …
Survey Sweepstakes Official Rules 1. NO PURCHASE NECESSARY. OPEN ONLY TO LEGAL RESIDENTS OF THE UNITED STATES OF AMERICA WHO ARE AT LEAST 18 YEARS OLD AND A MEDICAL PROVIDER AT TIME OF ENTRY. Void where prohibited by law. This sweepstakes begins on October 4, 2023, at 12:01 a.m. ET and ends on October 6, 2023, 10:00 a.m. CT (“Promotion Period”). Sponsor’s computer is the official time keeping …
September 13, 2023
Review key issues and takeaways during early phases of this ovarian cancer care quality improvement initiative.
September 12, 2023
Join us for a complimentary evening of golf, cocktails and networking at our Meet & Greet Reception, hosted by the Nevada Oncology Society (NOS). This event will take place on Tuesday, September 12th, after the Nevada Cancer Control Summit. The reception presents a fantastic opportunity to connect with local oncology professionals and attendees. You don't have to be a NOS member to …
PowerPoint Presentation Template 3 Nina Sanford, MD Assistant Professor Department of Radiation Oncology UTSW Simmons Comprehensive Cancer Center @NiuSanford Radiotherapy in Rectal Cancer: Personalizing Treatment to Improve Quality of Life September 13, 2023 2 Outline • Rationale for radiotherapy in rectal cancer • Choosing the appropriate radiotherapy regimen …
Mayo Clinic Oncology Review 2023 MANAGEMENT OF LOCALLY ADVANCED RECTAL CANCER: MEDICAL ONCOLOGY PERSPECTIVE Joleen Hubbard, MD Gastrointestinal Oncologist Deputy Director of Clinical Research and Academic Affairs Allina Health Cancer Institute Associate Professor of Medical Oncology Mayo Clinic, Rochester, MN ©2023 Mayo Foundation for Medical Education …